rss
J Neurol Neurosurg Psychiatry 2000;68:275-276 doi:10.1136/jnnp.68.3.275
  • Editorial commentary

Corticobasal degeneration

  1. A KERTESZ
  1. Department of Clinical Neurological Sciences, University of Western Ontario, St Joseph's Hospital, 268 Grosvenor Street, London, Ontario N6A 4V2, Canada
  2. kertesz@lri.stjosephs.london.on.ca

      Corticobasal ganglionic degeneration (CBGD) or corticobasal degeneration (CBD) is a pathological diagnosis in search of a nosological niche. It was originally described as corticodentatonigral degeneration by Rebeizet al,1 who recognised its relation to Pick's disease because of the focal cortical atrophy and the ballooned neurons (Pick cells). The clinical syndrome was first characterised by a combination of unilateral extrapyramidal signs and prominent apraxia, usually diagnosed in movement disorder clinics. …

      Register for free content

      The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

      BMJ Careers - Latest neurology and neurosurgery jobs